$EDIT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Editas Medicine, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Editas Medicine, Inc.. Get notifications about new insider transactions in Editas Medicine, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 3,600 | 40,356 | 3,600 | 0 to 3.6 K |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 29.65 | 3,000 | 88,950 | 0 | 3 K to 0 (-100.00 %) |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Aug 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 30.12 | 2,100 | 63,252 | 1,276,966 | 1.3 M to 1.3 M (-0.16 %) |
| Aug 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.36 | 6,233 | 183,001 | 1,279,066 | 1.3 M to 1.3 M (-0.48 %) |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 7,000 | 78,470 | 76,897 | |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 7,000 | 4,550 | 97,307 | |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 36.25 | 850 | 30,813 | 0 | 850 to 0 (-100.00 %) |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 850 | 9,529 | 850 | 0 to 850 |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 35.46 | 6,150 | 218,079 | 0 | 6.2 K to 0 (-100.00 %) |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 6,150 | 68,942 | 6,150 | 0 to 6.2 K |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 36.50 | 4,000 | 146,000 | 0 | 4 K to 0 (-100.00 %) |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 4,000 | 2,600 | 4,000 | 0 to 4 K |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 34.66 | 3,000 | 103,980 | 0 | 3 K to 0 (-100.00 %) |
| Jul 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Jul 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.46 | 5,333 | 194,441 | 1,285,299 | 1.3 M to 1.3 M (-0.41 %) |
| Jul 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.00 | 3,000 | 108,000 | 1,290,632 | 1.3 M to 1.3 M (-0.23 %) |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 7,000 | 78,470 | 83,897 | |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 7,000 | 4,550 | 104,307 | |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 38.39 | 7,000 | 268,730 | 0 | 7 K to 0 (-100.00 %) |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 7,000 | 78,470 | 7,000 | 0 to 7 K |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 38.71 | 2,700 | 104,517 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 2,700 | 1,755 | 2,700 | 0 to 2.7 K |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 37.75 | 4,300 | 162,325 | 0 | 4.3 K to 0 (-100.00 %) |
| Jun 20 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 4,300 | 2,795 | 4,300 | 0 to 4.3 K |
| Jun 19 2018 | EDIT | Editas Medicine, I ... | Nikolic Boris | Director | Option Exercise | A | 37.50 | 11,538 | 432,675 | 11,538 | |
| Jun 19 2018 | EDIT | Editas Medicine, I ... | Vaishnaw Akshay | Director | Option Exercise | A | 37.50 | 11,538 | 432,675 | 11,538 | |
| Jun 19 2018 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 37.50 | 11,538 | 432,675 | 11,538 | |
| Jun 15 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 205,000 | |
| Jun 15 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 35.98 | 10,000 | 359,800 | 0 | 10 K to 0 (-100.00 %) |
| Jun 15 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Buy | M | 16.51 | 10,000 | 165,100 | 10,000 | 0 to 10 K |
| Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 39.96 | 300 | 11,988 | 1,293,632 | 1.3 M to 1.3 M (-0.02 %) |
| Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 39.15 | 800 | 31,320 | 1,293,932 | 1.3 M to 1.3 M (-0.06 %) |
| Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.81 | 1,019 | 38,528 | 1,294,732 | 1.3 M to 1.3 M (-0.08 %) |
| Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.18 | 6,214 | 231,037 | 1,295,751 | 1.3 M to 1.3 M (-0.48 %) |
| May 25 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 215,000 | |
| May 25 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 35.00 | 10,000 | 350,000 | 0 | 10 K to 0 (-100.00 %) |
| May 25 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Buy | M | 16.51 | 10,000 | 165,100 | 10,000 | 0 to 10 K |
| May 22 2018 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | Director | Buy | P | 38.03 | 10,000 | 380,252 | 10,000 | 0 to 10 K |
| May 21 2018 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Buy | P | 37.28 | 6,700 | 249,780 | 6,700 | 0 to 6.7 K |
| May 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.95 | 8,333 | 266,239 | 1,301,965 | 1.3 M to 1.3 M (-0.64 %) |
| Apr 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.61 | 3,500 | 114,135 | 1,310,298 | 1.3 M to 1.3 M (-0.27 %) |
| Apr 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.83 | 4,833 | 153,834 | 1,313,798 | 1.3 M to 1.3 M (-0.37 %) |
| Mar 28 2018 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | Director | Option Exercise | A | 33.18 | 23,076 | 765,662 | 23,076 | |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 24.60 | 22,000 | 541,200 | 70,500 | |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 6,000 | 38,880 | 48,513 | |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 6,000 | 38,880 | 54,513 | |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 6,000 | 38,880 | 60,513 | |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 37.91 | 22,000 | 834,020 | 0 | 22 K to 0 (-100.00 %) |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 24.60 | 22,000 | 541,200 | 22,000 | 0 to 22 K |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 38.39 | 1,000 | 38,390 | 0 | 1,000 to 0 (-100.00 %) |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 1,000 | 6,480 | 1,000 | 0 to 1,000 |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 37.51 | 5,000 | 187,550 | 0 | 5 K to 0 (-100.00 %) |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 5,000 | 32,400 | 5,000 | 0 to 5 K |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 37.65 | 6,000 | 225,900 | 0 | 6 K to 0 (-100.00 %) |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 6,000 | 38,880 | 6,000 | 0 to 6 K |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 39.43 | 6,000 | 236,580 | 0 | 6 K to 0 (-100.00 %) |
| Mar 20 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 6,000 | 38,880 | 6,000 | 0 to 6 K |
| Mar 13 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 45.00 | 9,134 | 411,030 | 1,318,631 | 1.3 M to 1.3 M (-0.69 %) |
| Mar 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.41 | 1,800 | 65,538 | 1,327,765 | 1.3 M to 1.3 M (-0.14 %) |
| Mar 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.87 | 4,800 | 172,176 | 1,329,565 | 1.3 M to 1.3 M (-0.36 %) |
| Mar 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 34.61 | 1,733 | 59,979 | 1,334,365 | 1.3 M to 1.3 M (-0.13 %) |
| Feb 16 2018 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Option Exercise | A | 34.59 | 23,076 | 798,199 | 23,076 | |
| Feb 09 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | A | 36.67 | 275,000 | 10,084,250 | 275,000 | |
| Feb 09 2018 | EDIT | Editas Medicine, I ... | Cox Gerald Frank | Chief Medical Offic ... | Option Exercise | A | 36.67 | 60,000 | 2,200,200 | 60,000 | |
| Feb 09 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 36.67 | 71,500 | 2,621,905 | 71,500 | |
| Feb 09 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | A | 36.67 | 95,000 | 3,483,650 | 95,000 | |
| Feb 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.60 | 700 | 26,322 | 1,336,098 | 1.3 M to 1.3 M (-0.05 %) |
| Feb 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.71 | 2,100 | 77,097 | 1,336,798 | 1.3 M to 1.3 M (-0.16 %) |
| Feb 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.79 | 5,533 | 198,032 | 1,338,898 | 1.3 M to 1.3 M (-0.41 %) |
| Jan 31 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 40.05 | 10,000 | 400,520 | 1,344,431 | 1.4 M to 1.3 M (-0.74 %) |
| Jan 31 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.53 | 10,000 | 375,340 | 1,354,431 | 1.4 M to 1.4 M (-0.73 %) |
| Jan 25 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.28 | 3,338 | 117,765 | 1,364,431 | 1.4 M to 1.4 M (-0.24 %) |
| Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.04 | 6,662 | 233,416 | 1,367,769 | 1.4 M to 1.4 M (-0.48 %) |
| Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 34.23 | 3,937 | 134,744 | 1,374,431 | 1.4 M to 1.4 M (-0.29 %) |
| Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 33.63 | 2,193 | 73,759 | 1,378,368 | 1.4 M to 1.4 M (-0.16 %) |
| Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.01 | 1,703 | 54,510 | 1,380,561 | 1.4 M to 1.4 M (-0.12 %) |
| Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.25 | 500 | 15,624 | 1,382,264 | 1.4 M to 1.4 M (-0.04 %) |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 4,649 | 15,016 | 130,427 | |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 5,000 | 16,150 | 135,076 | |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 5,000 | 16,150 | 140,076 | |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 25.06 | 4,649 | 116,510 | 0 | 4.6 K to 0 (-100.00 %) |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 4,649 | 15,016 | 4,649 | 0 to 4.6 K |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 24.68 | 5,000 | 123,409 | 0 | 5 K to 0 (-100.00 %) |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 5,000 | 16,150 | 5,000 | 0 to 5 K |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 24.31 | 5,000 | 121,546 | 0 | 5 K to 0 (-100.00 %) |
| Dec 19 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 5,000 | 16,150 | 5,000 | 0 to 5 K |
| Dec 05 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.88 | 5,133 | 153,348 | 1,382,764 | 1.4 M to 1.4 M (-0.37 %) |
| Dec 05 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.12 | 3,200 | 93,174 | 1,387,897 | 1.4 M to 1.4 M (-0.23 %) |
| Nov 21 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 5,000 | 16,150 | 145,076 | |
| Nov 21 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 5,000 | 16,150 | 150,076 | |
| Nov 21 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 25.35 | 5,000 | 126,732 | 0 | 5 K to 0 (-100.00 %) |
| Nov 21 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 5,000 | 16,150 | 5,000 | 0 to 5 K |
| Nov 21 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 24.81 | 5,000 | 124,073 | 0 | 5 K to 0 (-100.00 %) |
| Nov 21 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 5,000 | 16,150 | 5,000 | 0 to 5 K |
| Nov 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 25.05 | 300 | 7,514 | 1,391,097 | 1.4 M to 1.4 M (-0.02 %) |
| Nov 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 24.25 | 1,925 | 46,679 | 1,391,397 | 1.4 M to 1.4 M (-0.14 %) |
| Nov 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 23.37 | 6,108 | 142,773 | 1,393,322 | 1.4 M to 1.4 M (-0.44 %) |
| Oct 04 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 25.33 | 200 | 5,066 | 1,399,430 | 1.4 M to 1.4 M (-0.01 %) |
| Oct 04 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 24.77 | 8,133 | 201,459 | 1,399,630 | 1.4 M to 1.4 M (-0.58 %) |
| Sep 06 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 20.20 | 6,666 | 134,681 | 1,407,763 | 1.4 M to 1.4 M (-0.47 %) |
| Sep 06 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 21.20 | 200 | 4,239 | 1,414,429 | 1.4 M to 1.4 M (-0.01 %) |
| Sep 06 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 20.40 | 9,800 | 199,911 | 1,414,629 | 1.4 M to 1.4 M (-0.69 %) |
| Aug 21 2017 | EDIT | Editas Medicine, I ... | Cole Douglas G. | Director | Buy | J | 0.00 | 1,686 | 0 | 3,171 | 1.5 K to 3.2 K (+113.54 %) |
| Jun 19 2017 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| Jun 19 2017 | EDIT | Editas Medicine, I ... | Cole Douglas G. | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| Jun 19 2017 | EDIT | Editas Medicine, I ... | MENDLEIN JOHN | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| Jun 19 2017 | EDIT | Editas Medicine, I ... | Nikolic Boris | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| Jun 19 2017 | EDIT | Editas Medicine, I ... | Borisy Alexis | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| Jun 06 2017 | EDIT | Editas Medicine, I ... | Cox Gerald Frank | Chief Medical Offic ... | Buy | P | 14.15 | 4,000 | 56,600 | 4,000 | 0 to 4 K |
| Jun 06 2017 | EDIT | Editas Medicine, I ... | Nikolic Boris | Director | Buy | P | 14.07 | 35,000 | 492,527 | 35,000 | 0 to 35 K |
| May 31 2017 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 13.75 | 23,076 | 317,295 | 23,076 | |
| May 24 2017 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 17.00 | 1,000,000 | 17,000,000 | 2,797,144 | 3.8 M to 2.8 M (-26.34 %) |
| Mar 17 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Option Exercise | M | 0.65 | 1,000 | 650 | 30,461 | |
| Mar 17 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Sell | S | 26.41 | 1,000 | 26,410 | 117,788 | 118.8 K to 117.8 K (-0.84 %) |
| Mar 17 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Buy | M | 0.65 | 1,000 | 650 | 118,788 | 117.8 K to 118.8 K (+0.85 %) |
| Mar 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | A | 24.60 | 312,000 | 7,675,200 | 312,000 | |
| Mar 03 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | A | 24.60 | 92,500 | 2,275,500 | 92,500 | |
| Mar 03 2017 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 24.60 | 45,000 | 1,107,000 | 45,000 | |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 3,000 | 9,690 | 155,076 | |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 19.20 | 3,000 | 57,600 | 0 | 3 K to 0 (-100.00 %) |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 3,000 | 9,690 | 3,000 | 0 to 3 K |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Option Exercise | M | 0.65 | 6,000 | 3,900 | 31,461 | |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Sell | S | 23.48 | 1,000 | 23,484 | 117,788 | 118.8 K to 117.8 K (-0.84 %) |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Sell | S | 20.00 | 5,000 | 100,000 | 118,788 | 123.8 K to 118.8 K (-4.04 %) |
| Feb 16 2017 | EDIT | Editas Medicine, I ... | Glucksmann Alexandra | Chief Operating Off ... | Buy | M | 0.65 | 6,000 | 3,900 | 123,788 | 117.8 K to 123.8 K (+5.09 %) |
| Jan 13 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 3.23 | 15,000 | 48,450 | 158,076 | |
| Jan 13 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 19.20 | 15,000 | 288,000 | 0 | 15 K to 0 (-100.00 %) |
| Jan 13 2017 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 3.23 | 15,000 | 48,450 | 15,000 | 0 to 15 K |
| Dec 08 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.82 | 75,000 | 1,186,500 | 3,797,144 | 3.9 M to 3.8 M (-1.94 %) |
| Dec 08 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 15.82 | 75,000 | 1,186,500 | 3,797,144 | 3.9 M to 3.8 M (-1.94 %) |
| Dec 07 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 15.87 | 50,000 | 793,500 | 3,872,144 | 3.9 M to 3.9 M (-1.27 %) |
| Dec 07 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 15.74 | 80,000 | 1,259,200 | 3,922,144 | 4 M to 3.9 M (-2.00 %) |
| Dec 07 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.87 | 50,000 | 793,500 | 3,872,144 | 3.9 M to 3.9 M (-1.27 %) |
| Dec 07 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.74 | 80,000 | 1,259,200 | 3,922,144 | 4 M to 3.9 M (-2.00 %) |
| Nov 28 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 15.71 | 21,480 | 337,451 | 4,002,144 | 4 M to 4 M (-0.53 %) |
| Nov 28 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.71 | 21,480 | 337,451 | 4,002,144 | 4 M to 4 M (-0.53 %) |
| Nov 23 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 15.77 | 12,819 | 202,156 | 4,023,624 | 4 M to 4 M (-0.32 %) |
| Nov 23 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.77 | 12,819 | 202,156 | 4,023,624 | 4 M to 4 M (-0.32 %) |
| Nov 18 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 16.30 | 30,830 | 502,529 | 4,036,443 | 4.1 M to 4 M (-0.76 %) |
| Nov 18 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 16.30 | 30,830 | 502,529 | 4,036,443 | 4.1 M to 4 M (-0.76 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 17.78 | 498 | 8,854 | 4,067,273 | 4.1 M to 4.1 M (-0.01 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 16.55 | 30,367 | 502,574 | 4,067,771 | 4.1 M to 4.1 M (-0.74 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 17.16 | 58,035 | 995,881 | 4,098,138 | 4.2 M to 4.1 M (-1.40 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 17.78 | 498 | 8,854 | 4,067,273 | 4.1 M to 4.1 M (-0.01 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 16.55 | 30,367 | 502,574 | 4,067,771 | 4.1 M to 4.1 M (-0.74 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 17.16 | 58,035 | 995,881 | 4,098,138 | 4.2 M to 4.1 M (-1.40 %) |
| Oct 06 2016 | EDIT | Editas Medicine, I ... | Cox Gerald Frank | Chief Medical Offic ... | Option Exercise | A | 15.48 | 225,000 | 3,483,000 | 225,000 | |
| Sep 13 2016 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 16.51 | 225,000 | 3,714,750 | 225,000 | |
| Sep 12 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 16.80 | 500,000 | 8,400,000 | 4,156,173 | 4.7 M to 4.2 M (-10.74 %) |